Nanotech breathing monitor aims to catch silent warnings before It's too late
NCT ID NCT07650539
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called RespiraFibre, a tiny sensor that attaches to oxygen masks or tubes to continuously measure breathing rate. Breathing rate is one of the best early signs that a patient is getting worse, but current methods are often inaccurate or skipped. The study will involve 148 hospital patients to see if the device is comfortable, easy to use, and accurate compared to standard monitoring.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- RespiraFibre nanotechnology breathing monitor (device)
- What this could lead to
- If successful, this could give doctors and nurses a simple, accurate way to detect early signs of serious illness in hospital patients, potentially saving lives and reducing costs.
- What could go wrong
- This is an early-stage feasibility study with only 148 participants. The device may not be accurate enough in real-world hospital settings, or patients and staff may find it uncomfortable or difficult to use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 148 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Have capacity to consent to the study * Undergoing surgery or receiving oxygen therapy Exclusion Criteria: * Inability to wear the monitor as designed
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Respiratory monitoring are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University College London Hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.